Test Price
3,500 AED✅ Home Collection Available
Gastrointestinal Stromal Tumor (GIST) Cancer Targeted Gene Panel Test in UAE | 3500 AED | 2026 DHA Guidelines
تحليل لوحة الجينات المستهدفة لورم الجهاز الهضمي السدوي (GIST) في الإمارات | 3500 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & UAE Clinical Assurance
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing, delivering reliable detection of KIT, PDGFRA, and other actionable mutations.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain and VIP Mobile Phlebotomy for safe transport of your FFPE block.
- Clinical Guidance: Complimentary post‑test telephonic guidance with a DHA‑licensed oncologist to interpret your results within the clinical context.
- Insurance Support: Direct billing verification and pre‑authorization assistance via WhatsApp +971 54 548 8731.
- يضمن هذا التحليل الجيني المتقدم اكتشاف الطفرات الورمية بدقة عالية مع خدمة سحب منزلي متميزة وتوجيه طبي متخصص بعد النتائج، وفقًا لأعلى معايير هيئة الصحة بدبي والقانون الاتحادي رقم 41 لسنة 2024.
Clinical Overview
The Gastrointestinal Stromal Tumor (GIST) Cancer Targeted Gene Panel is a comprehensive next‑generation sequencing (NGS) assay that simultaneously interrogates key oncogenic drivers – primarily KIT and PDGFRA mutations – to guide tyrosine kinase inhibitor therapy. يوفر هذا الفحص الشامل تحديدًا دقيقًا للطفرات الجينية في أورام الجهاز الهضمي السدوية لتوجيه العلاج الموجه بدقة عالية.
| Feature | Our GIST NGS Panel (ISO‑Accredited) | Standard IHC‑Only Alternative |
|---|---|---|
| Methodology | NGS + Immunohistochemistry + Fragment Analysis | Immunohistochemistry (IHC) only |
| Detection Sensitivity | >99% for clinically actionable mutations | ~70% (limited to protein expression) |
| Turn‑Around Time | 10 Working Days | 7 Working Days |
| Price | 3500 AED | ~1500 AED |
| DHA / MOHAP Compliance | Full – ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Variable |
Physician Insight & Safety Protocol
From Dr. Prabhakar Reddy – DHA License 61713011, Consultant Oncologist: “As your oncologist, I understand the deep concern that accompanies a GIST diagnosis. This targeted gene panel is a crucial tool to move beyond uncertainty – it precisely identifies the mutation driving your tumour, directly shaping a therapy that is both personalized and effective. Please remember that all results must be correlated with your full clinical picture and discussed with your treating physician.”
⚠️ Important Medication Warning
Do not discontinue any prescribed medication or alter your treatment regimen without a direct consultation with your doctor. Gene panel results inform therapy decisions; they do not replace ongoing clinical management.
Patient Safety & Exclusion Criteria
- Exclusion criteria: Insufficient viable tumour content in the paraffin block (<20% cellularity), decalcified tissue, or specimens fixed in non‑formalin agents. Lack of a fully completed NGS Test Requisition Form (Form 40) and signed informed consent for genetic testing is an absolute exclusion.
- Emergency Red Flags: If you experience sudden severe abdominal pain, persistent vomiting, complete inability to pass stool or gas, or alarming weight loss, seek immediate emergency medical attention. The gene panel is a diagnostic tool, not an emergency intervention.
Frequently Asked Questions
What does the GIST cancer targeted gene panel test for?
Direct Answer: This advanced NGS panel identifies mutations in KIT, PDGFRA, and other critical genes to guide precision targeted therapy for gastrointestinal stromal tumours. The analysis covers all clinically relevant exons of KIT (exons 9, 11, 13, 17) and PDGFRA (exons 12, 14, 18), as well as rare drivers such as BRAF and SDH modifications. A definitive molecular diagnosis enables oncologists to select the most effective tyrosine kinase inhibitor and avoid therapies unlikely to work.
ما هي التحضيرات اللازمة قبل إرسال العينة؟
إجابة مباشرة: يجب تقديم كتلة نسيجية مثبتة بالفورمالين ومضمنة بالبارافين (FFPE) مع استمارة طلب التحليل الجيني (النموذج 40) مكتملة وموقعة. يجب شحن الكتلة في درجة حرارة الغرفة مع وثائق تعريف العينة الكاملة. سيقوم فريق السحب المنزلي المعتمد بتأمين النقل وفق معايير ISO الصارمة، مما يضمن سلامة العينة من لحظة استلامها حتى وصولها إلى المختبر.
How long does it take to receive the results and how are they delivered?
Direct Answer: Results are typically reported within 10 working days after sample receipt on Tuesday before 9 AM, providing rapid, actionable data for treatment planning. Reports are securely delivered via encrypted PDF to the requesting physician and the patient portal. A DHA‑licensed oncologist will offer a complimentary post‑ telephonic consultation to walk you through the findings, answer questions, and discuss next steps in coordination with your primary oncologist.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians